Investigating a receptor involved in Alzheimer's disease

Chemical Tools to Target TREM2 in Alzheimer's Disease

NIH-funded research Wichita State University · NIH-10869791

This study is looking at a special protein called TREM2 to see how it works in Alzheimer's disease, with the goal of finding new ways to treat the condition.

Quick facts

Grant typeR15 grant
Study typeNIH-funded research
Funding institutionWichita State University NIH-funded
Lab location1 site (Wichita, United States)
Project IDNIH-10869791 on NIH RePORTER

What this research studies

This research focuses on understanding the role of a specific receptor, TREM2, in Alzheimer's disease. Researchers aim to develop new chemical tools to study how TREM2 functions and its potential as a therapeutic target. The project involves creating synthetic methods to produce TREM2 and developing probes to identify its receptors and activation mechanisms. By gaining insights into TREM2, the research hopes to pave the way for new treatment strategies for Alzheimer's disease.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals diagnosed with Alzheimer's disease or those at risk of developing it.

Not a fit: Patients with other forms of dementia unrelated to Alzheimer's may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new therapeutic strategies for treating Alzheimer's disease.

How similar studies have performed: Previous studies have shown promise in targeting TREM2 for Alzheimer's treatment, indicating potential for success in this approach.

Where this research is happening

Wichita, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndromeAlzheimer's Disease
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.